非小细胞肺癌中癌症相关成纤维细胞的组织病理学分布特征及预后价值
该研究回顾性纳入243例接受根治性手术的非小细胞肺癌患者,利用组织芯片和多重免疫荧光检测SMA+ CAF在肿瘤中心与侵袭边缘的密度。结果显示肺鳞癌与肺腺癌的SMA+ CAF空间分布无差异,IM SMA+ CAF/TC SMA+ CAF比值是肺鳞癌RFS的独立危险因素(HR=2.833,95%CI:1.187~6.671,P=0.019)。
要点
- 肺鳞癌与肺腺癌的SMA+ CAF空间分布无统计学差异。
- IM SMA+ CAF/TC SMA+ CAF比值越高,肺鳞癌患者术后复发风险越高。
- 辅助化疗是肺腺癌患者RFS的独立危险因素(HR=2.682)。
核心结论
- 肺鳞癌与肺腺癌的SMA+ CAF空间分布无差异。
- IM SMA+ CAF/TC SMA+ CAF比值越高的肺鳞癌患者越容易术后复发。
研究设计与样本
- 回顾性收集2014年1月1日至2018年12月31日山东省肿瘤医院接受根治性手术的243例非小细胞肺癌患者。
- 利用术后石蜡标本构建包含肿瘤中心(TC)和侵袭边缘(IM)区域的组织芯片,采用多重免疫荧光检测SMA+ CAF密度。
主要发现
- 243例患者中,肺鳞癌83例,随访期间复发30例(36.1%);肺腺癌160例,复发46例(28.8%)。
- TC和IM区域中,肺鳞癌组与肺腺癌组的整体及上皮、间质SMA+ CAF差异均无统计学意义(均P>0.05)。
关键数值与推荐
- 多因素Cox回归显示IM SMA+ CAF/TC SMA+ CAF为肺鳞癌RFS的独立危险因素(HR=2.833,95%CI:1.187~6.671,P=0.019)。
- 辅助化疗为肺腺癌RFS的独立危险因素(HR=2.682,95%CI:1.178~6.006,P=0.019)。
临床怎么用
- 对于肺鳞癌患者,可关注IM SMA+ CAF/TC SMA+ CAF比值以评估术后复发风险。
- 肺腺癌患者辅助化疗与RFS相关,需结合临床综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the expression differences of smooth muscle actin (SMA)-positive cancer-associated fibroblasts (CAF) in different regions of lung squamous carcinoma and lung adenocarcinoma, as well as to analyze their prognostic value. Methods: Data of a total of 243 non-small cell lung cancer patients who underwent radical surgery from January 1, 2014 to December 31, 2018 at Shandong Cancer Hospital were retrospectively collected. Tissue microarrays containing the tumor center (TC) and invasive margin (IM) regions were constructed using patients' postoperative paraffin specimens, and the densities of SMA+ CAF within the total, epithelial, and stromal regions were detected using multiplex immunofluorescence. The recurrence-free survival time (RFS) of patients was obtained by the electronic case system or telephone follow-up, and univariate and multivariate Cox regression analyses were used to clarify the factors influencing the postoperative recurrence of patients. Results: Of the 243 patients, there were 83 cases of lung squamous carcinoma, with 30 (36.1%) recurrences during the follow-up period, and 160 cases of lung adenocarcinoma, with 46 (28.8%) recurrences during the follow-up period. In the TC and IM regions, the differences between the lung squamous carcinoma group and the lung adenocarcinoma group in total, epithelial, and stromal SMA+ CAF were not statistically significant (all P>0.05). Multifactorial Cox regression analysis showed that IM SMA+ CAF/TC SMA+ CAF was an independent risk factor for RFS in patients with lung squamous carcinoma (HR=2.833, 95% CI: 1.187-6.671, P=0.019), and adjuvant chemotherapy was an independent risk factor for RFS in patients with lung adenocarcinoma (HR=2.682, 95% CI: 1.178-6.006, P=0.019). Conclusions: There was no difference in the spatial distribution of SMA+ CAF between lung squamous carcinoma and lung adenocarcinoma. Patients with higher IM SMA+ CAF/TC SMA+ CAF ratios were more prone to postoperative recurrence in lung squamous carcinoma. 目的: 探讨平滑肌肌动蛋白(SMA)阳性的癌症相关成纤维细胞(CAF)在肺鳞状细胞癌(简称肺鳞癌)和肺腺癌不同区域中的表达差异及其预后价值。 方法: 回顾性收集2014年1月1日至2018年12月31日在山东省肿瘤医院接受根治性手术的243例非小细胞肺癌患者。利用患者的术后石蜡标本构建包含肿瘤中心(TC)和侵袭边缘(IM)区域的组织芯片,采用多重免疫荧光技术检测整体、上皮及间质区内SMA+ CAF的密度。通过电子病历系统或电话随访获取患者的无复发生存时间(RFS),采用单因素及多因素Cox回归分析明确患者术后复发的影响因素。 结果: 243例患者中,肺鳞癌83例,随访期间复发30例(36.1%);肺腺癌160例,随访期间复发46例(28.8%)。在TC和IM区域中,肺鳞癌组与肺腺癌组的整体及上皮、间质SMA+ CAF差异均无统计学意义(均P>0.05)。多因素Cox回归分析显示,IM SMA+ CAF/TC SMA+ CAF为肺鳞癌患者RFS的独立危险因素(HR=2.833,95%CI:1.187~6.671,P=0.019),辅助化疗为肺腺癌患者RFS的独立危险因素(HR=2.682,95% CI:1.178~6.006,P=0.019)。 结论: 肺鳞癌与肺腺癌的SMA+ CAF空间分布无差异。IM SMA+ CAF/TC SMA+ CAF比值越高的肺鳞癌患者越容易术后复发。.
引用
- Zhao YM, Yang LY, Ye DM, et al. [Histopathological distribution characteristics and prognostic value of cancer-associated fibroblasts in non-small cell lung cancer]. Zhonghua Zhong Liu Za Zhi. 2026. PMID: 41688209. doi:10.3760/cma.j.cn112152-20250717-00346
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。